Cipla Claims Success With Advair Trial

Indian Firm Has Warned FDA Review Could Last Two Years

 
• By Dean Rudge
  
Human_Respiratory_System
Cipla says the US market for Advair was worth almost $3bn over the last 12 months • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products